Health Canada
- Status: approved
🇨🇦 Dupilumab therapy in Canada
Dupilumab therapy (Dupilumab therapy) regulatory status in Canada.
Marketing authorisation
Dupilumab therapy in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Canada
Frequently asked questions
Is Dupilumab therapy approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Dupilumab therapy in Canada?
National Medical Research Center for Children's Health, Russian Federation is the originator. The local marketing authorisation holder may differ — check the official source linked above.